EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial

Ine Simal iD, Annemie Somers iD, Cheima Amrouch iD, Andreas Capiau iD, Antonio Cherubini, Alfonso J Cruz-Jentoft iD, Adalsteinn Gudmundsson iD, Roy L Soiza iD, Denis O 'Mahony iD, Mirko Petrovic iD

European Geriatric Medicine · 02.08.2024 · 15 (5) · 1357-1367

DOI: 10.1007/s41999-024-01025-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Geriatric Medicine, online erschienen am 02.08.2024. Verfasst von Ine Simal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Ghent University Hospital, Ghent, Belgium. ine.simal@uzgent.be. Hauptthemen laut MEDLINE: Drug Interactions, Drug-Related Side Effects and Adverse Reactions, Multimorbidity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Drug-drug interactions (DDIs) are prevalent among multimorbid and polymedicated older adults and can increase the risk of adverse drug reactions (ADRs), hospital admissions, and mortality. This study describes the incidence and prevalence of 66 clinically relevant DDIs and analyses the occurrence of 12 corresponding predefined ADRs in older inpatients enrolled in the SENATOR trial. METHODS: The sub-study of the SENATOR trial that involved 1537 multimorbid older inpatients, recruited from 2016 to 2018 in six academic teaching hospitals in Belgium, Iceland, Ireland, Italy, Scotland, and Spain respectively, and analysed 66 potentially clinically significant DDIs. Descriptive analysis determined DDI and corresponding ADR prevalence/incidence. RESULTS: At baseline (median age: 78 [72, 84], 52.8% male), the prevalence of patients with DDIs was high (50.9%), increased during hospitalisation (55.2%) and reduced to 49.7% after 12 weeks. The most common DDIs were: ≥ 2 potassium reducing drugs (17.1%), ≥ 3 centrally acting drugs (9.0%), and SSRI + loop/thiazide diuretic (7.2%). Of all participants, one-third experienced a prevalent (36.6%)/incident (35.8%) ADR. Major serum electrolyte disturbance had the highest incidence (10.7%)/prevalence (11.5%). Incident ADRs were more common in patients with DDIs (p = 0.013). A higher prevalence of new onset falls (p = 0.013), major constipation (p = 0.004), and major serum electrolyte disturbances (p = 0.006) was observed in patients with related and thus potentially causal DDIs. CONCLUSIONS: Clinicians should, be aware of DDIs and the involved drug classes that can lead to an increased rate of ADRs in older multimorbid inpatients. Regularly reevaluating the appropriateness of the frequently prescribed drug classes and initiating judicious deprescribing is recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug InteractionsDrug-Related Side Effects and Adverse ReactionsMultimorbidityAgedAged, 80 and overFemaleHumansMaleHospitalizationIncidenceInpatientsPolypharmacyPrevalence

Stichwörter der Autor:innen

Adverse drug reactionsDrug-drug-interactionsMultimorbidityOlder adultsPolypharmacy

Autor:innen und Institutionen

  • Department of Pharmacy, Ghent University Hospital, Ghent, Belgium. ine.simal@uzgent.be.
  • Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium. ine.simal@uzgent.be.
  • Department of Pharmacy, Ghent University Hospital, Ghent, Belgium.
  • Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
  • Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
  • Geriatria, Accettazione Geriatrica e Centro di Ricerca per l'Invecchiamento, IRCCS INRCA, 60127, Ancona, Italy.

ORCID-Profile: Ine Simal, Annemie Somers, Cheima Amrouch, Andreas Capiau, Alfonso J Cruz-Jentoft, Adalsteinn Gudmundsson, Roy L Soiza, Denis O 'Mahony, Mirko Petrovic

Zitieren

APA

Simal, I., Somers, A., Amrouch, C., Capiau, A., Cherubini, A., Cruz-Jentoft, A. J., Gudmundsson, A., Soiza, R. L., O 'Mahony, D., & Petrovic, M. (2024). A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial. European Geriatric Medicine, 15(5), 1357-1367. https://doi.org/10.1007/s41999-024-01025-7

Vancouver

Simal I, Somers A, Amrouch C, Capiau A, Cherubini A, Cruz-Jentoft AJ, et al. A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial. European Geriatric Medicine. 2024;15(5):1357-1367. doi:10.1007/s41999-024-01025-7

BibTeX
@article{Simal2024,
  author = {Simal, Ine and Somers, Annemie and Amrouch, Cheima and Capiau, Andreas and Cherubini, Antonio and Cruz-Jentoft, Alfonso J and Gudmundsson, Adalsteinn and Soiza, Roy L and O 'Mahony, Denis and Petrovic, Mirko},
  title = {A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial},
  journal = {European Geriatric Medicine},
  year = {2024},
  volume = {15},
  number = {5},
  pages = {1357--1367},
  doi = {10.1007/s41999-024-01025-7}
}
Kostenlos starten →